REG - Spectral MD Holdings - Statement re. Silicon Valley Bank

Spectral MD HoldingsAnnouncement

13/03/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230313:nRSM6639Sa&default-theme=true

RNS Number : 6639S  Spectral MD Holdings, Ltd.  13 March 2023

Spectral MD Holdings, Ltd.

        ("Spectral MD" or the
"Company")

 

Statement re. Silicon Valley Bank

 

LONDON, U.K. AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a
predictive analytics company with proprietary AI algorithms and optical
technology for faster and more accurate treatment decisions in wound care, is
aware of public statements and media reports relating to Silicon Valley Bank
("SVB"). The Company does not have any cash deposits with SVB nor does it have
any banking relationship with SVB.

 

For further information please contact:

 

 Spectral MD Holdings, Ltd.                        investors.spectralmd.com
 Wensheng Fan, Chief Executive Officer             via Walbrook PR
 Nils Windler, Chief Financial Officer

 SP Angel Corporate Finance LLP (NOMAD and Joint Broker)                                             Tel: +44 (0)20 3470 0470
 Stuart Gledhill/Harry Davies-Ball (Corporate Finance)

 Vadim Alexandre/Rob Rees (Sales & Broking)

 Stifel Nicolaus Europe Limited (Joint Broker)     Tel: +44 (0)20 7710 7600

 Charles Hoare / Ben Maddison / Nick Harland

 Will Palmer-Brown

 Walbrook PR Ltd (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com
 Paul McManus / Louis Ashe-Jepson /                Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393

 Alice Woodings                                    +44 (0)7407 804 654

 

About Spectral MD:
 

We are a dedicated team of forward-thinkers striving to revolutionize the
management of wound care by "Seeing the Unknown" ® with our DeepView(®)
Wound Imaging System.

www.spectralmd.com

info@spectralmd.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRSFMEFEEDSESD